nodes	percent_of_prediction	percent_of_DWPC	metapath
Prednisolone—CYP3A4—Temozolomide—malignant glioma	0.175	1	CbGbCtD
Prednisolone—Monoplegia—Carmustine—malignant glioma	0.0538	0.119	CcSEcCtD
Prednisolone—Hyperadrenocorticism—Temozolomide—malignant glioma	0.052	0.115	CcSEcCtD
Prednisolone—Meningitis—Carmustine—malignant glioma	0.0215	0.0476	CcSEcCtD
Prednisolone—Intracranial pressure increased—Carmustine—malignant glioma	0.0199	0.0441	CcSEcCtD
Prednisolone—Impaired healing—Carmustine—malignant glioma	0.0192	0.0426	CcSEcCtD
Prednisolone—Embolism—Temozolomide—malignant glioma	0.0125	0.0278	CcSEcCtD
Prednisolone—Myopathy—Temozolomide—malignant glioma	0.0115	0.0254	CcSEcCtD
Prednisolone—Abscess—Carmustine—malignant glioma	0.0105	0.0233	CcSEcCtD
Prednisolone—Petechiae—Temozolomide—malignant glioma	0.00978	0.0217	CcSEcCtD
Prednisolone—Viral infection—Temozolomide—malignant glioma	0.00891	0.0197	CcSEcCtD
Prednisolone—Herpes simplex—Temozolomide—malignant glioma	0.00873	0.0193	CcSEcCtD
Prednisolone—Neuropathy—Carmustine—malignant glioma	0.00782	0.0173	CcSEcCtD
Prednisolone—Neuropathy—Temozolomide—malignant glioma	0.00755	0.0167	CcSEcCtD
Prednisolone—Thrombophlebitis—Carmustine—malignant glioma	0.00698	0.0155	CcSEcCtD
Prednisolone—Diabetes mellitus—Carmustine—malignant glioma	0.00695	0.0154	CcSEcCtD
Prednisolone—Thrombophlebitis—Temozolomide—malignant glioma	0.00675	0.0149	CcSEcCtD
Prednisolone—Injury—Carmustine—malignant glioma	0.00657	0.0146	CcSEcCtD
Prednisolone—NR3C2—brainstem—malignant glioma	0.00604	0.0542	CbGeAlD
Prednisolone—NR3C2—retina—malignant glioma	0.00583	0.0523	CbGeAlD
Prednisolone—Affect lability—Temozolomide—malignant glioma	0.00575	0.0127	CcSEcCtD
Prednisolone—Mood swings—Temozolomide—malignant glioma	0.00553	0.0123	CcSEcCtD
Prednisolone—NR3C2—telencephalon—malignant glioma	0.00536	0.0481	CbGeAlD
Prednisolone—Dry skin—Temozolomide—malignant glioma	0.00535	0.0119	CcSEcCtD
Prednisolone—Muscular weakness—Carmustine—malignant glioma	0.00533	0.0118	CcSEcCtD
Prednisolone—Muscular weakness—Temozolomide—malignant glioma	0.00515	0.0114	CcSEcCtD
Prednisolone—Abdominal distension—Temozolomide—malignant glioma	0.00508	0.0113	CcSEcCtD
Prednisolone—Sweating increased—Temozolomide—malignant glioma	0.00492	0.0109	CcSEcCtD
Prednisolone—SLCO1A2—telencephalon—malignant glioma	0.0046	0.0412	CbGeAlD
Prednisolone—Weight increased—Temozolomide—malignant glioma	0.00459	0.0102	CcSEcCtD
Prednisolone—Neuropathy peripheral—Carmustine—malignant glioma	0.00456	0.0101	CcSEcCtD
Prednisolone—Neuropathy peripheral—Temozolomide—malignant glioma	0.00441	0.00977	CcSEcCtD
Prednisolone—NR3C2—medulla oblongata—malignant glioma	0.00421	0.0378	CbGeAlD
Prednisolone—Haemoglobin—Carmustine—malignant glioma	0.0042	0.00931	CcSEcCtD
Prednisolone—Haemorrhage—Carmustine—malignant glioma	0.00418	0.00926	CcSEcCtD
Prednisolone—Haemoglobin—Temozolomide—malignant glioma	0.00406	0.00899	CcSEcCtD
Prednisolone—Haemorrhage—Temozolomide—malignant glioma	0.00404	0.00895	CcSEcCtD
Prednisolone—Visual impairment—Carmustine—malignant glioma	0.00403	0.00892	CcSEcCtD
Prednisolone—Visual impairment—Temozolomide—malignant glioma	0.00389	0.00862	CcSEcCtD
Prednisolone—NR3C2—midbrain—malignant glioma	0.00385	0.0346	CbGeAlD
Prednisolone—NR3C2—spinal cord—malignant glioma	0.00376	0.0337	CbGeAlD
Prednisolone—Arrhythmia—Carmustine—malignant glioma	0.00373	0.00827	CcSEcCtD
Prednisolone—SERPINA6—central nervous system—malignant glioma	0.00373	0.0335	CbGeAlD
Prednisolone—SERPINA6—cerebellum—malignant glioma	0.00365	0.0327	CbGeAlD
Prednisolone—Erythema—Carmustine—malignant glioma	0.00364	0.00806	CcSEcCtD
Prednisolone—SLCO1A2—medulla oblongata—malignant glioma	0.00361	0.0324	CbGeAlD
Prednisolone—NR3C1—embryo—malignant glioma	0.00354	0.0317	CbGeAlD
Prednisolone—Erythema—Temozolomide—malignant glioma	0.00352	0.00779	CcSEcCtD
Prednisolone—Vision blurred—Carmustine—malignant glioma	0.00343	0.0076	CcSEcCtD
Prednisolone—Vision blurred—Temozolomide—malignant glioma	0.00331	0.00734	CcSEcCtD
Prednisolone—SLCO1A2—midbrain—malignant glioma	0.0033	0.0296	CbGeAlD
Prednisolone—Ill-defined disorder—Temozolomide—malignant glioma	0.00326	0.00723	CcSEcCtD
Prednisolone—NR3C1—brainstem—malignant glioma	0.00324	0.0291	CbGeAlD
Prednisolone—SLCO1A2—spinal cord—malignant glioma	0.00322	0.0289	CbGeAlD
Prednisolone—Angioedema—Temozolomide—malignant glioma	0.00321	0.00712	CcSEcCtD
Prednisolone—CYP2A6—cerebellum—malignant glioma	0.00318	0.0285	CbGeAlD
Prednisolone—ABCB1—blood vessel—malignant glioma	0.00317	0.0285	CbGeAlD
Prednisolone—Malaise—Temozolomide—malignant glioma	0.00317	0.00702	CcSEcCtD
Prednisolone—Vertigo—Temozolomide—malignant glioma	0.00316	0.007	CcSEcCtD
Prednisolone—Convulsion—Carmustine—malignant glioma	0.00315	0.00698	CcSEcCtD
Prednisolone—Hypertension—Carmustine—malignant glioma	0.00314	0.00696	CcSEcCtD
Prednisolone—NR3C2—central nervous system—malignant glioma	0.00305	0.0273	CbGeAlD
Prednisolone—Convulsion—Temozolomide—malignant glioma	0.00305	0.00675	CcSEcCtD
Prednisolone—Hypertension—Temozolomide—malignant glioma	0.00304	0.00672	CcSEcCtD
Prednisolone—NR3C2—cerebellum—malignant glioma	0.00298	0.0267	CbGeAlD
Prednisolone—Oedema—Carmustine—malignant glioma	0.00297	0.00658	CcSEcCtD
Prednisolone—SERPINA6—brain—malignant glioma	0.00296	0.0266	CbGeAlD
Prednisolone—Discomfort—Temozolomide—malignant glioma	0.00296	0.00655	CcSEcCtD
Prednisolone—Tachycardia—Carmustine—malignant glioma	0.0029	0.00642	CcSEcCtD
Prednisolone—NR3C1—telencephalon—malignant glioma	0.00288	0.0258	CbGeAlD
Prednisolone—Oedema—Temozolomide—malignant glioma	0.00287	0.00636	CcSEcCtD
Prednisolone—Anaphylactic shock—Temozolomide—malignant glioma	0.00287	0.00636	CcSEcCtD
Prednisolone—Hyperhidrosis—Temozolomide—malignant glioma	0.00277	0.00615	CcSEcCtD
Prednisolone—Insomnia—Carmustine—malignant glioma	0.00269	0.00595	CcSEcCtD
Prednisolone—Paraesthesia—Carmustine—malignant glioma	0.00267	0.00591	CcSEcCtD
Prednisolone—SLCO1A2—central nervous system—malignant glioma	0.00261	0.0234	CbGeAlD
Prednisolone—Insomnia—Temozolomide—malignant glioma	0.0026	0.00575	CcSEcCtD
Prednisolone—CYP2A6—brain—malignant glioma	0.00258	0.0232	CbGeAlD
Prednisolone—Paraesthesia—Temozolomide—malignant glioma	0.00258	0.00571	CcSEcCtD
Prednisolone—SLCO1A2—cerebellum—malignant glioma	0.00255	0.0229	CbGeAlD
Prednisolone—Pain—Carmustine—malignant glioma	0.00254	0.00562	CcSEcCtD
Prednisolone—Pain—Temozolomide—malignant glioma	0.00245	0.00544	CcSEcCtD
Prednisolone—Feeling abnormal—Carmustine—malignant glioma	0.00245	0.00542	CcSEcCtD
Prednisolone—NR3C2—brain—malignant glioma	0.00242	0.0217	CbGeAlD
Prednisolone—Feeling abnormal—Temozolomide—malignant glioma	0.00237	0.00524	CcSEcCtD
Prednisolone—Urticaria—Temozolomide—malignant glioma	0.00228	0.00505	CcSEcCtD
Prednisolone—NR3C1—medulla oblongata—malignant glioma	0.00226	0.0203	CbGeAlD
Prednisolone—Hypersensitivity—Carmustine—malignant glioma	0.00219	0.00485	CcSEcCtD
Prednisolone—Hypersensitivity—Temozolomide—malignant glioma	0.00211	0.00468	CcSEcCtD
Prednisolone—SLCO1A2—brain—malignant glioma	0.00207	0.0186	CbGeAlD
Prednisolone—NR3C1—midbrain—malignant glioma	0.00207	0.0185	CbGeAlD
Prednisolone—NR3C1—spinal cord—malignant glioma	0.00202	0.0181	CbGeAlD
Prednisolone—Dizziness—Carmustine—malignant glioma	0.00196	0.00435	CcSEcCtD
Prednisolone—Dizziness—Temozolomide—malignant glioma	0.0019	0.0042	CcSEcCtD
Prednisolone—ABCB1—embryo—malignant glioma	0.00189	0.017	CbGeAlD
Prednisolone—Rash—Carmustine—malignant glioma	0.00187	0.00415	CcSEcCtD
Prednisolone—Dermatitis—Carmustine—malignant glioma	0.00187	0.00414	CcSEcCtD
Prednisolone—Headache—Carmustine—malignant glioma	0.00186	0.00412	CcSEcCtD
Prednisolone—Rash—Temozolomide—malignant glioma	0.00181	0.00401	CcSEcCtD
Prednisolone—Dermatitis—Temozolomide—malignant glioma	0.00181	0.004	CcSEcCtD
Prednisolone—Headache—Temozolomide—malignant glioma	0.0018	0.00398	CcSEcCtD
Prednisolone—Methyltestosterone—CYP2B6—malignant glioma	0.00179	0.243	CrCbGaD
Prednisolone—Nausea—Carmustine—malignant glioma	0.00176	0.00391	CcSEcCtD
Prednisolone—Triamcinolone—BCHE—malignant glioma	0.00172	0.233	CrCbGaD
Prednisolone—Nausea—Temozolomide—malignant glioma	0.0017	0.00378	CcSEcCtD
Prednisolone—ABCB1—retina—malignant glioma	0.00167	0.015	CbGeAlD
Prednisolone—NR3C1—central nervous system—malignant glioma	0.00163	0.0147	CbGeAlD
Prednisolone—NR3C1—cerebellum—malignant glioma	0.0016	0.0143	CbGeAlD
Prednisolone—ABCB1—telencephalon—malignant glioma	0.00154	0.0138	CbGeAlD
Prednisolone—NR3C1—brain—malignant glioma	0.0013	0.0116	CbGeAlD
Prednisolone—CYP3A4—central nervous system—malignant glioma	0.00124	0.0111	CbGeAlD
Prednisolone—ABCB1—medulla oblongata—malignant glioma	0.00121	0.0109	CbGeAlD
Prednisolone—ABCB1—midbrain—malignant glioma	0.00111	0.00992	CbGeAlD
Prednisolone—ABCB1—spinal cord—malignant glioma	0.00108	0.00968	CbGeAlD
Prednisolone—Testosterone—CYP2B6—malignant glioma	0.00104	0.141	CrCbGaD
Prednisolone—Dexamethasone—CYP2B6—malignant glioma	0.001	0.136	CrCbGaD
Prednisolone—ABCB1—central nervous system—malignant glioma	0.000875	0.00785	CbGeAlD
Prednisolone—ABCB1—cerebellum—malignant glioma	0.000855	0.00768	CbGeAlD
Prednisolone—Triamcinolone—PTGS2—malignant glioma	0.000792	0.108	CrCbGaD
Prednisolone—ABCB1—brain—malignant glioma	0.000695	0.00624	CbGeAlD
Prednisolone—Betamethasone—PTGS2—malignant glioma	0.000649	0.0881	CrCbGaD
Prednisolone—NR3C1—Adipogenesis—NCOR1—malignant glioma	0.000622	0.00244	CbGpPWpGaD
Prednisolone—NR3C1—SIDS Susceptibility Pathways—GJA1—malignant glioma	0.00062	0.00243	CbGpPWpGaD
Prednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—STMN1—malignant glioma	0.000617	0.00242	CbGpPWpGaD
Prednisolone—NR3C1—AP-1 transcription factor network—CDKN2A—malignant glioma	0.000615	0.00241	CbGpPWpGaD
Prednisolone—SLCO1A2—SLC-mediated transmembrane transport—SLC5A5—malignant glioma	0.000606	0.00237	CbGpPWpGaD
Prednisolone—NR3C2—Gene Expression—DNMT3B—malignant glioma	0.000603	0.00236	CbGpPWpGaD
Prednisolone—CYP3A4—Phase 1 - Functionalization of compounds—CYP2C18—malignant glioma	0.000601	0.00236	CbGpPWpGaD
Prednisolone—NR3C1—AP-1 transcription factor network—IFNG—malignant glioma	0.0006	0.00235	CbGpPWpGaD
Prednisolone—NR3C2—Gene Expression—HIST1H3B—malignant glioma	0.000586	0.0023	CbGpPWpGaD
Prednisolone—SLCO1A2—SLC-mediated transmembrane transport—SLC6A3—malignant glioma	0.000577	0.00226	CbGpPWpGaD
Prednisolone—CYP2A6—Fluoropyrimidine Activity—TP53—malignant glioma	0.000564	0.00221	CbGpPWpGaD
Prednisolone—NR3C1—AP-1 transcription factor network—CXCL8—malignant glioma	0.000558	0.00219	CbGpPWpGaD
Prednisolone—CYP2A6—NRF2 pathway—GSTP1—malignant glioma	0.000557	0.00218	CbGpPWpGaD
Prednisolone—NR3C1—SIDS Susceptibility Pathways—HES1—malignant glioma	0.000541	0.00212	CbGpPWpGaD
Prednisolone—NR3C1—AP-1 transcription factor network—IL2—malignant glioma	0.000533	0.00209	CbGpPWpGaD
Prednisolone—NR3C1—Glucocorticoid receptor regulatory network—IFNG—malignant glioma	0.000529	0.00207	CbGpPWpGaD
Prednisolone—NR3C1—Glucocorticoid receptor regulatory network—MDM2—malignant glioma	0.000526	0.00206	CbGpPWpGaD
Prednisolone—NR3C1—Adipogenesis—HIF1A—malignant glioma	0.000524	0.00206	CbGpPWpGaD
Prednisolone—ABCB1—HIF-1-alpha transcription factor network—TERT—malignant glioma	0.000507	0.00199	CbGpPWpGaD
Prednisolone—NR3C1—AP-1 transcription factor network—MMP9—malignant glioma	0.000505	0.00198	CbGpPWpGaD
Prednisolone—NR3C1—AP-1 transcription factor network—PTEN—malignant glioma	0.000502	0.00197	CbGpPWpGaD
Prednisolone—CYP3A4—Tryptophan metabolism—CAT—malignant glioma	0.000501	0.00196	CbGpPWpGaD
Prednisolone—CYP2A6—Metabolism—RTEL1—malignant glioma	0.000494	0.00194	CbGpPWpGaD
Prednisolone—NR3C1—Glucocorticoid receptor regulatory network—CXCL8—malignant glioma	0.000492	0.00193	CbGpPWpGaD
Prednisolone—SLCO1A2—Metabolism of lipids and lipoproteins—IDH1—malignant glioma	0.000491	0.00192	CbGpPWpGaD
Prednisolone—NR3C2—Generic Transcription Pathway—NOTCH1—malignant glioma	0.00049	0.00192	CbGpPWpGaD
Prednisolone—CYP2A6—Biological oxidations—GSTP1—malignant glioma	0.000488	0.00191	CbGpPWpGaD
Prednisolone—ABCB1—HIF-1-alpha transcription factor network—HIF1A—malignant glioma	0.000484	0.0019	CbGpPWpGaD
Prednisolone—ABCB1—Allograft Rejection—PDGFRA—malignant glioma	0.000477	0.00187	CbGpPWpGaD
Prednisolone—SLCO1A2—Metabolism of lipids and lipoproteins—SPHK1—malignant glioma	0.000475	0.00186	CbGpPWpGaD
Prednisolone—ABCB1—Allograft Rejection—HLA-B—malignant glioma	0.000473	0.00186	CbGpPWpGaD
Prednisolone—NR3C1—Glucocorticoid receptor regulatory network—IL2—malignant glioma	0.00047	0.00184	CbGpPWpGaD
Prednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—PLK1—malignant glioma	0.000468	0.00183	CbGpPWpGaD
Prednisolone—NR3C2—Generic Transcription Pathway—PPARG—malignant glioma	0.000462	0.00181	CbGpPWpGaD
Prednisolone—CYP3A4—Phase 1 - Functionalization of compounds—PTGS1—malignant glioma	0.000456	0.00179	CbGpPWpGaD
Prednisolone—NR3C1—SIDS Susceptibility Pathways—HIF1A—malignant glioma	0.000453	0.00178	CbGpPWpGaD
Prednisolone—NR3C2—Gene Expression—H3F3A—malignant glioma	0.000453	0.00177	CbGpPWpGaD
Prednisolone—NR3C1—Adipogenesis—PPARG—malignant glioma	0.000446	0.00175	CbGpPWpGaD
Prednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—WT1—malignant glioma	0.000443	0.00174	CbGpPWpGaD
Prednisolone—CYP2A6—NRF2 pathway—PDGFB—malignant glioma	0.00044	0.00173	CbGpPWpGaD
Prednisolone—ABCB1—Allograft Rejection—HLA-A—malignant glioma	0.000439	0.00172	CbGpPWpGaD
Prednisolone—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—malignant glioma	0.000431	0.00169	CbGpPWpGaD
Prednisolone—NR3C2—Gene Expression—NOTCH3—malignant glioma	0.000425	0.00167	CbGpPWpGaD
Prednisolone—NR3C1—FOXA2 and FOXA3 transcription factor networks—AKT1—malignant glioma	0.000419	0.00164	CbGpPWpGaD
Prednisolone—NR3C1—AP-1 transcription factor network—MYC—malignant glioma	0.000417	0.00163	CbGpPWpGaD
Prednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—PML—malignant glioma	0.000395	0.00155	CbGpPWpGaD
Prednisolone—SLCO1A2—Metabolism—COX8A—malignant glioma	0.000394	0.00155	CbGpPWpGaD
Prednisolone—NR3C2—Gene Expression—NOTCH2—malignant glioma	0.000381	0.00149	CbGpPWpGaD
Prednisolone—Dexamethasone—PTGS2—malignant glioma	0.000377	0.0513	CrCbGaD
Prednisolone—NR3C1—Regulation of nuclear SMAD2/3 signaling—MYC—malignant glioma	0.000371	0.00145	CbGpPWpGaD
Prednisolone—ABCB1—Allograft Rejection—CD80—malignant glioma	0.00037	0.00145	CbGpPWpGaD
Prednisolone—CYP3A4—Biological oxidations—CYP2B6—malignant glioma	0.000368	0.00144	CbGpPWpGaD
Prednisolone—CYP3A4—Metapathway biotransformation—CYP2B6—malignant glioma	0.000363	0.00142	CbGpPWpGaD
Prednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—TOP2A—malignant glioma	0.000361	0.00142	CbGpPWpGaD
Prednisolone—ABCB1—Transmembrane transport of small molecules—COX8A—malignant glioma	0.00036	0.00141	CbGpPWpGaD
Prednisolone—SLCO1A2—Metabolism of lipids and lipoproteins—PTGS1—malignant glioma	0.000353	0.00138	CbGpPWpGaD
Prednisolone—NR3C1—AP-1 transcription factor network—TP53—malignant glioma	0.000342	0.00134	CbGpPWpGaD
Prednisolone—SLCO1A2—Metabolism—ASMT—malignant glioma	0.000335	0.00131	CbGpPWpGaD
Prednisolone—SLCO1A2—Transmembrane transport of small molecules—TFRC—malignant glioma	0.000335	0.00131	CbGpPWpGaD
Prednisolone—ABCB1—Transmembrane transport of small molecules—FTH1—malignant glioma	0.00033	0.00129	CbGpPWpGaD
Prednisolone—SLCO1A2—Metabolism of lipids and lipoproteins—BCHE—malignant glioma	0.000328	0.00128	CbGpPWpGaD
Prednisolone—NR3C2—Gene Expression—CDKN2B—malignant glioma	0.000328	0.00128	CbGpPWpGaD
Prednisolone—CYP3A4—Biological oxidations—CYP2C18—malignant glioma	0.000319	0.00125	CbGpPWpGaD
Prednisolone—SLCO1A2—Metabolism—BCAN—malignant glioma	0.000315	0.00124	CbGpPWpGaD
Prednisolone—CYP3A4—Metapathway biotransformation—CYP2C18—malignant glioma	0.000315	0.00124	CbGpPWpGaD
Prednisolone—NR3C1—Generic Transcription Pathway—NOTCH3—malignant glioma	0.000311	0.00122	CbGpPWpGaD
Prednisolone—NR3C2—Gene Expression—NCOR1—malignant glioma	0.000311	0.00122	CbGpPWpGaD
Prednisolone—SLCO1A2—Transmembrane transport of small molecules—SLC5A5—malignant glioma	0.000308	0.00121	CbGpPWpGaD
Prednisolone—NR3C1—Glucocorticoid receptor regulatory network—TP53—malignant glioma	0.000302	0.00118	CbGpPWpGaD
Prednisolone—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—malignant glioma	0.000298	0.00117	CbGpPWpGaD
Prednisolone—NR3C1—SIDS Susceptibility Pathways—CXCL8—malignant glioma	0.000294	0.00115	CbGpPWpGaD
Prednisolone—ABCB1—Metabolism—RTEL1—malignant glioma	0.000294	0.00115	CbGpPWpGaD
Prednisolone—SLCO1A2—Transmembrane transport of small molecules—SLC6A3—malignant glioma	0.000293	0.00115	CbGpPWpGaD
Prednisolone—ABCB1—Allograft Rejection—IFNG—malignant glioma	0.000293	0.00115	CbGpPWpGaD
Prednisolone—ABCB1—Transmembrane transport of small molecules—ATP1B2—malignant glioma	0.000288	0.00113	CbGpPWpGaD
Prednisolone—CYP2A6—Metabolism—COX8A—malignant glioma	0.000284	0.00111	CbGpPWpGaD
Prednisolone—NR3C1—SIDS Susceptibility Pathways—IL1B—malignant glioma	0.000282	0.00111	CbGpPWpGaD
Prednisolone—NR3C1—SIDS Susceptibility Pathways—CASP3—malignant glioma	0.000281	0.0011	CbGpPWpGaD
Prednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—NTRK1—malignant glioma	0.000281	0.0011	CbGpPWpGaD
Prednisolone—ABCB1—Transmembrane transport of small molecules—APOD—malignant glioma	0.00028	0.0011	CbGpPWpGaD
Prednisolone—NR3C1—Generic Transcription Pathway—NOTCH2—malignant glioma	0.000279	0.00109	CbGpPWpGaD
Prednisolone—CYP3A4—Tryptophan metabolism—MDM2—malignant glioma	0.000276	0.00108	CbGpPWpGaD
Prednisolone—NR3C1—Adipogenesis—STAT3—malignant glioma	0.000274	0.00107	CbGpPWpGaD
Prednisolone—ABCB1—Allograft Rejection—CXCL8—malignant glioma	0.000272	0.00107	CbGpPWpGaD
Prednisolone—NR3C2—Generic Transcription Pathway—MYC—malignant glioma	0.000264	0.00103	CbGpPWpGaD
Prednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—BRCA2—malignant glioma	0.000261	0.00102	CbGpPWpGaD
Prednisolone—ABCB1—Allograft Rejection—IL1B—malignant glioma	0.000261	0.00102	CbGpPWpGaD
Prednisolone—ABCB1—Allograft Rejection—CASP3—malignant glioma	0.00026	0.00102	CbGpPWpGaD
Prednisolone—ABCB1—Allograft Rejection—IL2—malignant glioma	0.00026	0.00102	CbGpPWpGaD
Prednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN2B—malignant glioma	0.000259	0.00102	CbGpPWpGaD
Prednisolone—CYP3A4—Biological oxidations—GSTT1—malignant glioma	0.000258	0.00101	CbGpPWpGaD
Prednisolone—NR3C1—Regulation of nuclear SMAD2/3 signaling—AKT1—malignant glioma	0.000257	0.00101	CbGpPWpGaD
Prednisolone—ABCB1—HIF-1-alpha transcription factor network—VEGFA—malignant glioma	0.000255	0.001	CbGpPWpGaD
Prednisolone—NR3C1—Glucocorticoid receptor regulatory network—AKT1—malignant glioma	0.000255	0.000999	CbGpPWpGaD
Prednisolone—SLCO1A2—Metabolism—IDH2—malignant glioma	0.000254	0.000996	CbGpPWpGaD
Prednisolone—CYP3A4—Biological oxidations—PTGS1—malignant glioma	0.000242	0.000949	CbGpPWpGaD
Prednisolone—CYP2A6—Metabolism—ASMT—malignant glioma	0.000241	0.000946	CbGpPWpGaD
Prednisolone—SLCO1A2—Metabolism of lipids and lipoproteins—NCOR1—malignant glioma	0.00024	0.000939	CbGpPWpGaD
Prednisolone—NR3C1—Generic Transcription Pathway—CDKN2B—malignant glioma	0.000239	0.000939	CbGpPWpGaD
Prednisolone—SLCO1A2—Metabolism—CYP2B6—malignant glioma	0.000239	0.000937	CbGpPWpGaD
Prednisolone—NR3C1—SIDS Susceptibility Pathways—VEGFA—malignant glioma	0.000239	0.000936	CbGpPWpGaD
Prednisolone—NR3C1—Adipogenesis—TNF—malignant glioma	0.000237	0.000928	CbGpPWpGaD
Prednisolone—NR3C2—Gene Expression—NOTCH1—malignant glioma	0.000236	0.000925	CbGpPWpGaD
Prednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—PDGFRA—malignant glioma	0.000235	0.000922	CbGpPWpGaD
Prednisolone—NR3C1—Generic Transcription Pathway—NCOR1—malignant glioma	0.000227	0.00089	CbGpPWpGaD
Prednisolone—CYP2A6—Metabolism—BCAN—malignant glioma	0.000227	0.000889	CbGpPWpGaD
Prednisolone—NR3C2—Gene Expression—PPARG—malignant glioma	0.000223	0.000873	CbGpPWpGaD
Prednisolone—ABCB1—Allograft Rejection—VEGFA—malignant glioma	0.000221	0.000867	CbGpPWpGaD
Prednisolone—SLCO1A2—Metabolism—IDH1—malignant glioma	0.000219	0.000857	CbGpPWpGaD
Prednisolone—NR3C1—Gene Expression—DNMT3B—malignant glioma	0.000212	0.000832	CbGpPWpGaD
Prednisolone—SLCO1A2—Metabolism—SPHK1—malignant glioma	0.000211	0.000829	CbGpPWpGaD
Prednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—FGFR1—malignant glioma	0.00021	0.000824	CbGpPWpGaD
Prednisolone—SLCO1A2—Metabolism—CYP2C18—malignant glioma	0.000207	0.000812	CbGpPWpGaD
Prednisolone—NR3C1—Gene Expression—HIST1H3B—malignant glioma	0.000206	0.000808	CbGpPWpGaD
Prednisolone—NR3C1—SIDS Susceptibility Pathways—TNF—malignant glioma	0.000205	0.000802	CbGpPWpGaD
Prednisolone—SLCO1A2—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	0.000195	0.000766	CbGpPWpGaD
Prednisolone—ABCB1—Allograft Rejection—TNF—malignant glioma	0.000189	0.000743	CbGpPWpGaD
Prednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—BAD—malignant glioma	0.000188	0.000738	CbGpPWpGaD
Prednisolone—CYP2A6—Metabolism—IDH2—malignant glioma	0.000183	0.000717	CbGpPWpGaD
Prednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—APC—malignant glioma	0.000182	0.000715	CbGpPWpGaD
Prednisolone—CYP3A4—Metabolism—RTEL1—malignant glioma	0.000181	0.00071	CbGpPWpGaD
Prednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—EGF—malignant glioma	0.00018	0.000707	CbGpPWpGaD
Prednisolone—CYP3A4—Biological oxidations—GSTP1—malignant glioma	0.000179	0.000702	CbGpPWpGaD
Prednisolone—SLCO1A2—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	0.000178	0.000697	CbGpPWpGaD
Prednisolone—CYP3A4—Metapathway biotransformation—GSTP1—malignant glioma	0.000177	0.000692	CbGpPWpGaD
Prednisolone—NR3C1—Generic Transcription Pathway—NOTCH1—malignant glioma	0.000172	0.000676	CbGpPWpGaD
Prednisolone—CYP2A6—Metabolism—CYP2B6—malignant glioma	0.000172	0.000674	CbGpPWpGaD
Prednisolone—SLCO1A2—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	0.000172	0.000673	CbGpPWpGaD
Prednisolone—ABCB1—Metabolism—COX8A—malignant glioma	0.000169	0.000662	CbGpPWpGaD
Prednisolone—SLCO1A2—Metabolism—GSTT1—malignant glioma	0.000168	0.000657	CbGpPWpGaD
Prednisolone—ABCB1—HIF-1-alpha transcription factor network—AKT1—malignant glioma	0.000163	0.000638	CbGpPWpGaD
Prednisolone—NR3C1—Generic Transcription Pathway—PPARG—malignant glioma	0.000163	0.000638	CbGpPWpGaD
Prednisolone—NR3C1—Gene Expression—H3F3A—malignant glioma	0.000159	0.000624	CbGpPWpGaD
Prednisolone—CYP2A6—Metabolism—IDH1—malignant glioma	0.000157	0.000616	CbGpPWpGaD
Prednisolone—SLCO1A2—Metabolism—PTGS1—malignant glioma	0.000157	0.000615	CbGpPWpGaD
Prednisolone—SLCO1A2—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	0.000156	0.000613	CbGpPWpGaD
Prednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—FGF2—malignant glioma	0.000154	0.000602	CbGpPWpGaD
Prednisolone—CYP2A6—Metabolism—SPHK1—malignant glioma	0.000152	0.000596	CbGpPWpGaD
Prednisolone—NR3C1—Gene Expression—NOTCH3—malignant glioma	0.00015	0.000586	CbGpPWpGaD
Prednisolone—CYP2A6—Metabolism—CYP2C18—malignant glioma	0.000149	0.000584	CbGpPWpGaD
Prednisolone—SLCO1A2—Metabolism—BCHE—malignant glioma	0.000146	0.000572	CbGpPWpGaD
Prednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—BCL2—malignant glioma	0.000146	0.000571	CbGpPWpGaD
Prednisolone—SLCO1A2—Metabolism—SLC5A5—malignant glioma	0.000144	0.000565	CbGpPWpGaD
Prednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—MDM2—malignant glioma	0.000144	0.000563	CbGpPWpGaD
Prednisolone—ABCB1—Metabolism—ASMT—malignant glioma	0.000144	0.000563	CbGpPWpGaD
Prednisolone—ABCB1—Transmembrane transport of small molecules—TFRC—malignant glioma	0.000143	0.000562	CbGpPWpGaD
Prednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—RAF1—malignant glioma	0.000143	0.000561	CbGpPWpGaD
Prednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—malignant glioma	0.000142	0.000555	CbGpPWpGaD
Prednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—malignant glioma	0.000138	0.000543	CbGpPWpGaD
Prednisolone—SLCO1A2—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	0.000136	0.000534	CbGpPWpGaD
Prednisolone—SLCO1A2—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	0.000135	0.00053	CbGpPWpGaD
Prednisolone—ABCB1—Metabolism—BCAN—malignant glioma	0.000135	0.000529	CbGpPWpGaD
Prednisolone—NR3C1—Gene Expression—NOTCH2—malignant glioma	0.000134	0.000526	CbGpPWpGaD
Prednisolone—SLCO1A2—Transmembrane transport of small molecules—RAF1—malignant glioma	0.000133	0.00052	CbGpPWpGaD
Prednisolone—ABCB1—Transmembrane transport of small molecules—SLC5A5—malignant glioma	0.000132	0.000517	CbGpPWpGaD
Prednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—malignant glioma	0.000129	0.000504	CbGpPWpGaD
Prednisolone—NR3C2—Gene Expression—MYC—malignant glioma	0.000127	0.000498	CbGpPWpGaD
Prednisolone—ABCB1—Transmembrane transport of small molecules—SLC6A3—malignant glioma	0.000125	0.000492	CbGpPWpGaD
Prednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—malignant glioma	0.000121	0.000473	CbGpPWpGaD
Prednisolone—CYP2A6—Metabolism—GSTT1—malignant glioma	0.000121	0.000472	CbGpPWpGaD
Prednisolone—SLCO1A2—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	0.000118	0.000462	CbGpPWpGaD
Prednisolone—SLCO1A2—Metabolism—GSTP1—malignant glioma	0.000116	0.000455	CbGpPWpGaD
Prednisolone—NR3C1—Gene Expression—CDKN2B—malignant glioma	0.000115	0.000452	CbGpPWpGaD
Prednisolone—SLCO1A2—Metabolism—CAT—malignant glioma	0.000113	0.000443	CbGpPWpGaD
Prednisolone—CYP2A6—Metabolism—PTGS1—malignant glioma	0.000113	0.000443	CbGpPWpGaD
Prednisolone—NR3C1—Gene Expression—NCOR1—malignant glioma	0.000109	0.000429	CbGpPWpGaD
Prednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—malignant glioma	0.000109	0.000428	CbGpPWpGaD
Prednisolone—ABCB1—Metabolism—IDH2—malignant glioma	0.000109	0.000426	CbGpPWpGaD
Prednisolone—SLCO1A2—Metabolism—NCOR1—malignant glioma	0.000107	0.000418	CbGpPWpGaD
Prednisolone—CYP2A6—Metabolism—BCHE—malignant glioma	0.000105	0.000412	CbGpPWpGaD
Prednisolone—CYP3A4—Metabolism—COX8A—malignant glioma	0.000104	0.000408	CbGpPWpGaD
Prednisolone—CYP2A6—Metabolism—SLC5A5—malignant glioma	0.000104	0.000407	CbGpPWpGaD
Prednisolone—ABCB1—Metabolism—CYP2B6—malignant glioma	0.000102	0.000401	CbGpPWpGaD
Prednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—malignant glioma	0.0001	0.000393	CbGpPWpGaD
Prednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—malignant glioma	9.82e-05	0.000385	CbGpPWpGaD
Prednisolone—ABCB1—Metabolism—IDH1—malignant glioma	9.35e-05	0.000367	CbGpPWpGaD
Prednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—malignant glioma	9.35e-05	0.000366	CbGpPWpGaD
Prednisolone—NR3C1—Generic Transcription Pathway—MYC—malignant glioma	9.28e-05	0.000364	CbGpPWpGaD
Prednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—malignant glioma	9.27e-05	0.000364	CbGpPWpGaD
Prednisolone—ABCB1—Metabolism—SPHK1—malignant glioma	9.05e-05	0.000355	CbGpPWpGaD
Prednisolone—ABCB1—Metabolism—CYP2C18—malignant glioma	8.87e-05	0.000348	CbGpPWpGaD
Prednisolone—CYP3A4—Metabolism—ASMT—malignant glioma	8.84e-05	0.000347	CbGpPWpGaD
Prednisolone—NR3C2—Gene Expression—AKT1—malignant glioma	8.8e-05	0.000345	CbGpPWpGaD
Prednisolone—SLCO1A2—Metabolism—CAV1—malignant glioma	8.7e-05	0.000341	CbGpPWpGaD
Prednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—malignant glioma	8.52e-05	0.000334	CbGpPWpGaD
Prednisolone—CYP2A6—Metabolism—GSTP1—malignant glioma	8.35e-05	0.000327	CbGpPWpGaD
Prednisolone—CYP3A4—Metabolism—BCAN—malignant glioma	8.31e-05	0.000326	CbGpPWpGaD
Prednisolone—SLCO1A2—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	8.31e-05	0.000326	CbGpPWpGaD
Prednisolone—NR3C1—Gene Expression—NOTCH1—malignant glioma	8.3e-05	0.000326	CbGpPWpGaD
Prednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—malignant glioma	8.24e-05	0.000323	CbGpPWpGaD
Prednisolone—CYP2A6—Metabolism—CAT—malignant glioma	8.13e-05	0.000319	CbGpPWpGaD
Prednisolone—SLCO1A2—Metabolism—PIK3CG—malignant glioma	7.92e-05	0.000311	CbGpPWpGaD
Prednisolone—NR3C1—Gene Expression—PPARG—malignant glioma	7.84e-05	0.000307	CbGpPWpGaD
Prednisolone—CYP2A6—Metabolism—NCOR1—malignant glioma	7.68e-05	0.000301	CbGpPWpGaD
Prednisolone—SLCO1A2—Metabolism—PPARG—malignant glioma	7.65e-05	0.0003	CbGpPWpGaD
Prednisolone—ABCB1—Metabolism—GSTT1—malignant glioma	7.17e-05	0.000281	CbGpPWpGaD
Prednisolone—SLCO1A2—Metabolism—PIK3CD—malignant glioma	6.97e-05	0.000273	CbGpPWpGaD
Prednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—malignant glioma	6.96e-05	0.000273	CbGpPWpGaD
Prednisolone—ABCB1—Metabolism—PTGS1—malignant glioma	6.72e-05	0.000263	CbGpPWpGaD
Prednisolone—CYP3A4—Metabolism—IDH2—malignant glioma	6.7e-05	0.000263	CbGpPWpGaD
Prednisolone—CYP3A4—Metabolism—CYP2B6—malignant glioma	6.3e-05	0.000247	CbGpPWpGaD
Prednisolone—CYP2A6—Metabolism—CAV1—malignant glioma	6.26e-05	0.000245	CbGpPWpGaD
Prednisolone—ABCB1—Metabolism—BCHE—malignant glioma	6.25e-05	0.000245	CbGpPWpGaD
Prednisolone—ABCB1—Metabolism—SLC5A5—malignant glioma	6.17e-05	0.000242	CbGpPWpGaD
Prednisolone—SLCO1A2—Metabolism—PIK3CB—malignant glioma	6.07e-05	0.000238	CbGpPWpGaD
Prednisolone—SLCO1A2—Metabolism—PTGS2—malignant glioma	6.02e-05	0.000236	CbGpPWpGaD
Prednisolone—CYP3A4—Metabolism—IDH1—malignant glioma	5.76e-05	0.000226	CbGpPWpGaD
Prednisolone—CYP2A6—Metabolism—PIK3CG—malignant glioma	5.7e-05	0.000223	CbGpPWpGaD
Prednisolone—ABCB1—Transmembrane transport of small molecules—RAF1—malignant glioma	5.68e-05	0.000223	CbGpPWpGaD
Prednisolone—CYP3A4—Metabolism—SPHK1—malignant glioma	5.58e-05	0.000219	CbGpPWpGaD
Prednisolone—CYP2A6—Metabolism—PPARG—malignant glioma	5.5e-05	0.000216	CbGpPWpGaD
Prednisolone—CYP3A4—Metabolism—CYP2C18—malignant glioma	5.46e-05	0.000214	CbGpPWpGaD
Prednisolone—SLCO1A2—Metabolism—PTEN—malignant glioma	5.25e-05	0.000206	CbGpPWpGaD
Prednisolone—CYP2A6—Metabolism—PIK3CD—malignant glioma	5.01e-05	0.000196	CbGpPWpGaD
Prednisolone—ABCB1—Metabolism—GSTP1—malignant glioma	4.97e-05	0.000195	CbGpPWpGaD
Prednisolone—ABCB1—Metabolism—CAT—malignant glioma	4.84e-05	0.00019	CbGpPWpGaD
Prednisolone—ABCB1—Metabolism—NCOR1—malignant glioma	4.57e-05	0.000179	CbGpPWpGaD
Prednisolone—NR3C1—Gene Expression—MYC—malignant glioma	4.47e-05	0.000175	CbGpPWpGaD
Prednisolone—CYP3A4—Metabolism—GSTT1—malignant glioma	4.42e-05	0.000173	CbGpPWpGaD
Prednisolone—CYP2A6—Metabolism—PIK3CB—malignant glioma	4.37e-05	0.000171	CbGpPWpGaD
Prednisolone—CYP2A6—Metabolism—PTGS2—malignant glioma	4.33e-05	0.00017	CbGpPWpGaD
Prednisolone—CYP3A4—Metabolism—PTGS1—malignant glioma	4.14e-05	0.000162	CbGpPWpGaD
Prednisolone—CYP3A4—Metabolism—BCHE—malignant glioma	3.85e-05	0.000151	CbGpPWpGaD
Prednisolone—CYP3A4—Metabolism—SLC5A5—malignant glioma	3.8e-05	0.000149	CbGpPWpGaD
Prednisolone—CYP2A6—Metabolism—PTEN—malignant glioma	3.77e-05	0.000148	CbGpPWpGaD
Prednisolone—ABCB1—Metabolism—CAV1—malignant glioma	3.72e-05	0.000146	CbGpPWpGaD
Prednisolone—SLCO1A2—Metabolism—PIK3CA—malignant glioma	3.7e-05	0.000145	CbGpPWpGaD
Prednisolone—ABCB1—Metabolism—PIK3CG—malignant glioma	3.39e-05	0.000133	CbGpPWpGaD
Prednisolone—ABCB1—Metabolism—PPARG—malignant glioma	3.27e-05	0.000128	CbGpPWpGaD
Prednisolone—NR3C1—Gene Expression—AKT1—malignant glioma	3.1e-05	0.000121	CbGpPWpGaD
Prednisolone—CYP3A4—Metabolism—GSTP1—malignant glioma	3.06e-05	0.00012	CbGpPWpGaD
Prednisolone—SLCO1A2—Metabolism—AKT1—malignant glioma	3.02e-05	0.000119	CbGpPWpGaD
Prednisolone—ABCB1—Metabolism—PIK3CD—malignant glioma	2.98e-05	0.000117	CbGpPWpGaD
Prednisolone—CYP3A4—Metabolism—CAT—malignant glioma	2.98e-05	0.000117	CbGpPWpGaD
Prednisolone—CYP3A4—Metabolism—NCOR1—malignant glioma	2.81e-05	0.00011	CbGpPWpGaD
Prednisolone—CYP2A6—Metabolism—PIK3CA—malignant glioma	2.66e-05	0.000104	CbGpPWpGaD
Prednisolone—ABCB1—Metabolism—PIK3CB—malignant glioma	2.6e-05	0.000102	CbGpPWpGaD
Prednisolone—ABCB1—Metabolism—PTGS2—malignant glioma	2.58e-05	0.000101	CbGpPWpGaD
Prednisolone—CYP3A4—Metabolism—CAV1—malignant glioma	2.29e-05	8.99e-05	CbGpPWpGaD
Prednisolone—ABCB1—Metabolism—PTEN—malignant glioma	2.25e-05	8.8e-05	CbGpPWpGaD
Prednisolone—CYP2A6—Metabolism—AKT1—malignant glioma	2.18e-05	8.53e-05	CbGpPWpGaD
Prednisolone—CYP3A4—Metabolism—PIK3CG—malignant glioma	2.09e-05	8.19e-05	CbGpPWpGaD
Prednisolone—CYP3A4—Metabolism—PPARG—malignant glioma	2.02e-05	7.91e-05	CbGpPWpGaD
Prednisolone—CYP3A4—Metabolism—PIK3CD—malignant glioma	1.84e-05	7.2e-05	CbGpPWpGaD
Prednisolone—CYP3A4—Metabolism—PIK3CB—malignant glioma	1.6e-05	6.28e-05	CbGpPWpGaD
Prednisolone—CYP3A4—Metabolism—PTGS2—malignant glioma	1.59e-05	6.22e-05	CbGpPWpGaD
Prednisolone—ABCB1—Metabolism—PIK3CA—malignant glioma	1.58e-05	6.21e-05	CbGpPWpGaD
Prednisolone—CYP3A4—Metabolism—PTEN—malignant glioma	1.38e-05	5.42e-05	CbGpPWpGaD
Prednisolone—ABCB1—Metabolism—AKT1—malignant glioma	1.29e-05	5.07e-05	CbGpPWpGaD
Prednisolone—CYP3A4—Metabolism—PIK3CA—malignant glioma	9.76e-06	3.83e-05	CbGpPWpGaD
Prednisolone—CYP3A4—Metabolism—AKT1—malignant glioma	7.97e-06	3.13e-05	CbGpPWpGaD
